Global Medical REIT (Global Medical REIT) Risk Assessment

View and export this data going back to 2012. Start your Free Trial

What is Global Medical REIT Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Global Medical REIT is: High Risk: High uncertainty.

Competitive Comparison of Global Medical REIT's Risk Assessment

For the REIT - Healthcare Facilities subindustry, Global Medical REIT's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Medical REIT's Risk Assessment Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Global Medical REIT's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Global Medical REIT's Risk Assessment falls into.

Global Medical REIT (NYSE:GMRE) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Global Medical REIT Risk Assessment Related Terms

Thank you for viewing the detailed overview of Global Medical REIT's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Medical REIT (Global Medical REIT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Global Medical REIT Inc (NYSE:GMRE) » Definitions » Risk Assessment

Comparable Companies

UHT DHC CHTH CHCT HLTC AHTR NHHS CVMCA STRW LTC WELL VTR PEAK OHI HR SBRA MPW DOC XBRU:AED NHI

Traded in Other Exchanges

GMREpA.PFD:USA 3UN:Germany 3UN:Germany

Address

7373 Wisconsin Avenue, Suite 800, Bethesda, MD, USA, 20814

Website

https://www.globalmedicalreit.com

Global Medical REIT Inc is a Maryland corporation engaged primarily in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to strong healthcare systems and physician groups. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases. Its tenants are physician groups, regional or national healthcare systems or combinations thereof. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation.

Executives

Moore Roscoe M Jr	director	C/O HEMOBIOTECH, INC., 5001 SPRING VALLEY ROAD, SUITE 1040 WEST, DALLAS TX 75244
Henry Cole	director	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Jeffrey Busch	director, officer: Chairman, President and CEO	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Lori Wittman	director	191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Matthew Cypher	director	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Paula Crowley	director	2 BETHESDA METRO CENTER, SUITE 440, BETHESDA MD 20814
Ronald Marston	director	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Robert J Kiernan	officer: Chief Financial Officer	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Alfonzo Leon	officer: Chief Investment Officer	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Danica Holley	officer: Chief Operating Officer	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Jamie Allen Barber	officer: Secretary and General Counsel	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Allen Webb	officer: SVP	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Huiqi Zhang	director, 10 percent owner	40-44 WYNDHAM STREET, 24/F WYNDHAM PLACE, HONG KONG K3 00000
Notable Reward Ltd	10 percent owner	VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110
Superior Glory Enterprises Ltd.	10 percent owner	VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110